Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > The Four Dollar Barrier Wall

<< Previous

Bullboard Posts

Next >>

Comment by 3burtcon Feb 03, 2021 11:46am

152 Views

Post# 32458679

RE:RE:RE:RE:RE:RE:The Four Dollar Barrier Wall

I'm glad it's not going up! I have plenty, but plenty isn't enough. When I first bought, I picked up 200 000 before the split. Then another 100 thousand using tactics that seemed to confuse this 4 dollar guy. Tried making it look like i only wanted a few hundred shares and he seemed to clue in . Last week I decided to pick up a few thousand here and there at market price. Mixing up your bids is critical. Me and some family members are watching daily, hoping it stays down. We've done the research and we know that oten annual revenues will be close to 10 billion annually. Glta, if buying mix up your strategy.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing